Danish diabetes hospital appointed as an international role model

Chronic diseases including diabetes pose major challenges for populations, healthcare and economies globally. Thus, it is necessary for the global healthcare systems to work towards a cross-sectoral oriented collaboration that provides more healthy lives for citizens with chronic diseases, a high user satisfaction in the treatment and new forms of treatment that are structurally and economically sustainable.

We are proud that we have been selected as a proof-of-concept for innovation in healthcare and look forward to collaborating with other Global Innovation Hubs around the world, from whom we can certainly learn a lot

Allan Flyvbjerg CEO, Steno Diabetes Center Copenhagen

Steno Diabetes Center Copenhagen is a Global Innovation Hub as it is one of the world's most advanced and innovative initiatives which helps strengthen the development towards a more coherent and efficient healthcare system that creates value for people living with diabetes.

The industry as a partner

Denmark has a long tradition for interdisciplinary, cross-sector collaboration and systematic public-private partnerships. The close collaboration between the private companies and the public healthcare system is important to secure new and innovative medicine and healthcare products for the patients.

Steno Diabetes Center Copenhagen is one of the early examples of a public-private collaboration. Steno Diabetes Center Copenhagen goes back to the Nordic Insulin Laboratory (now Novo Nordisk) established back in 1923. In 1932, the company established the first Nordic Diabetes Hospital to treat people with diabetes and the public healthcare system soon realized the potential and entered into a collaboration with the Life Science industry.

Today, Steno Diabetes Center Copenhagen is a public-private partnership between the Capital Region of Denmark and the Novo Nordisk Foundation. The Novo Nordisk Foundation has donated €0.4 billion for further development of the hospital. With the recognition from the World Economic Forum, Steno Diabetes Center Copenhagen enters a small group of world leading healthcare providers, each selected to be a showcase for the rest of the world in relation to disseminating examples of value-based healthcare with a sharp focus on creating the greatest possible value for the individual citizen.

It is an amazing recognition of the important work being performed at Steno Diabetes Center Copenhagen and the other regional Steno Diabetes Centres. I hope that it will inspire others and accelerate innovation in the treatment of diabetes and other non-communicable diseases globally

Lars Rebien Sørensen Chairman of Board of Directors, Novo Nordisk Foundation

Some of the remarkable results that the public-private cooperation has achieved so far include that almost no one goes blind because of diabetes as well as an 80 percent reduction in diabetes-related leg amputations.

Watch a video about the Danish approach to public-private partnerships by Healthcare Denmark

About

The World Economic Forum, committed to improving the state of the world, is the International Organization for Public-Private Cooperation. The Global Coalition for Value in Healthcare, hosted by the World Economic Forum, is a public-private collaboration to accelerate value-based health system transformation. The Global Innovation Hub for Value in Healthcare serve as a collaboration platform.

The Danish healthcare system is a universal coverage system providing free and equal access to healthcare for all Danish citizens, financed via taxes. The five Danish regions are responsible for hospitals and local general practitioners while the 98 municipalities are responsible for rehabilitation, prevention and elderly care. The Capital Region of Denmark is on number of inhabitants the largest of Denmark's five regions. The Capital Region of Denmark runs hospitals within somatic- and psychiatry diseases as well as research and education. The Capital Region has approximately 44,000 employees and a total annual budget of almost €5 billion.

Read more about the Capital Region of Denmark

The Novo Nordisk Foundation is an independent Danish foundation with corporate interests. It has two objectives: 1) to provide a stable basis for the commercial and research activities of the companies in the Novo Group; and 2) to support scientific, humanitarian and social causes.

Get in touch Want to know more about SDCC and Public-Private Partnerships within Life Sciences?

Please contact our dedicated life science experts here:

Loading...